Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 76Sarcoma 72Burkitt Lymphoma 59Lymphoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Non-Hodgkin 53Lymphoma, Follicular 49Lymphoma, Mantle-Cell 48Leukemia 48Lymphoma, Large-Cell, Immunoblastic 47Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Acute 43Hodgkin Disease 42Myelodysplastic Syndromes 41Multiple Myeloma 40Recurrence 39Leukemia, Myeloid, Chronic-Phase 32Leukemia, Myeloid, Accelerated Phase 31Blast Crisis 30Neoplasms, Plasma Cell 28Sarcoma, Ewing 25Rhabdomyosarcoma 25Osteosarcoma 24Myeloproliferative Disorders 24Neuroblastoma 23Leukemia, Myelomonocytic, Chronic 21Congenital Abnormalities 21Melanoma 20

Interventions

sargramostim 1indolepropanol phosphate 1Vincristine 1Tirapazamine 1Pharmacogenomic Testing 1Irinotecan 1Ifosfamide 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Alveolar Childhood Rhabdomyosarcoma × Cyclophosphamide × Sarcoma × Clear all
NCT00025363 2013-01-17

Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma

National Cancer Institute (NCI)

Phase 2 Completed
150 enrolled
Sarcoma

Alveolar Childhood Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡